Ye Xu
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 1%
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 67
- Colorectal Cancer Surgical Treatments 34
- Colorectal Cancer Treatments and Studies 18
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Sanjun Cai (36 shared papers)Xinxiang Li (23 shared papers)Jun Shen (2 shared papers)Zhihua Ran (1 shared paper)Guoxiang Cai (12 shared papers)Weixing Dai (26 shared papers)Sanjun Cai (14 shared papers)Fangqi Liu (27 shared papers)
- Journals
- Annals of Oncology (6 papers)BMC Cancer (6 papers)International Journal of Colorectal Disease (6 papers)Annals of Translational Medicine (5 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ye Xu
183 papers receiving 5.8k citations
Ye Xu's Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 1.8k
- Oncology 1.5k
- Molecular Biology 2.5k
- Immunology 627
- Pathology and Forensic Medicine 382
Countries citing papers authored by Ye Xu
This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).
Fields of papers citing papers by Ye Xu
This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer Hit paper breakdown → | 2020 | 593 |
| 2 | Emerging views of mitophagy in immunity and autoimmune diseases Hit paper breakdown → | 2019 | 402 |
| 3 | 2009 | 333 | |
| 4 | High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. | 2014 | 229 |
| 5 | 2016 | 222 | |
| 6 | 2010 | 192 | |
| 7 | 2016 | 130 | |
| 8 | 2015 | 130 | |
| 9 | 2020 | 126 | |
| 10 | 2016 | 102 | |
| 11 | 2021 | 101 | |
| 12 | 2020 | 94 | |
| 13 | 2013 | 84 | |
| 14 | 2023 | 79 | |
| 15 | 2022 | 77 | |
| 16 | 2016 | 77 | |
| 17 | 2021 | 73 | |
| 18 | 2020 | 72 | |
| 19 | 2014 | 70 | |
| 20 | 2010 | 69 |
About Ye Xu
Ye Xu is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 191 papers that have together received 5.9k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (34 papers), Genetic factors in colorectal cancer (22 papers), Colorectal Cancer Treatments and Studies (18 papers), Colorectal and Anal Carcinomas (14 papers), Cancer-related molecular mechanisms research (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (1.5k citations), Molecular Biology (2.5k citations), Immunology (627 citations) and Pathology and Forensic Medicine (382 citations). Ye Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Sanjun Cai, Xinxiang Li, Jun Shen, Zhihua Ran, Guoxiang Cai, Weixing Dai, Sanjun Cai, Fangqi Liu, Ping Wei and Dawei Li. Their work appears in journals such as Annals of Oncology, BMC Cancer, International Journal of Colorectal Disease, Annals of Translational Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.